Reborn Tech Scholar

Chapter 336 Publication of Papers (for Subscription)

Chapter 336 Publication of Papers (for Subscription)

337 Chapter Papers Published

The publication of papers is only a phased result.

It represents the results of laboratory research. There is no problem in theoretical research, and there are enough experimental samples and experimental data.

But a mouse is a mouse after all, and a human is a human after all!

Therefore, it will enter the second phase, which is to cooperate with hospitals and scientific research institutions to carry out clinical trials. In China, the application of a drug must undergo Phase III clinical trials in China to ensure its safety before it is allowed to be officially approved. drug.

Many people are blaming Huaxia, why they are not allowed to enter the Huaxia market even though there are many medicines with good curative effects overseas, which makes patients lose their lives without medicines.In fact, it is because these drugs are only undergoing clinical trials overseas, but they have not carried out Phase III clinical trials in China in accordance with China's regulations. Since they are not in accordance with China's regulations, the relevant departments will naturally not allow them to enter.

Who knows whether the overseas clinical trials of these drugs are falsified?Who knows that these medicines can be applied to Westerners, but whether they can be applied to Chinese people?
And not only Phase III clinical trials, but also Phase IV clinical trials and even EAP clinical trials when necessary.

Qin Yuanqing didn't pay any more attention to the clinical trial stage, and left it to the researchers and partner hospitals.

"Shuimu Natural Science Journal", founded in 1986, now has a composite impact factor of 1.612 and a comprehensive impact factor of 1.138. It only ranks second in the national university journals, and ranks about 2 in the national ranking. As for the international The above ranking belongs to the third-rate level.

Although "Journal of Shuimu Natural Sciences" also has excellent papers included in SCI, most of the content is not influential. Only 4 papers were selected in the whole year of last year.

The editorial department of "Journal of Water and Wood Natural Sciences" just received nine papers. At first, they didn't take it seriously. It is precisely because of this that "Shuimu Natural Science Journal" will not strive for rankings.

But when they saw that the corresponding author of the paper was Qin Yuanqing, the first author was Yan Ning, the second author was Guo Zhenhua and other [-] researchers, and all nine papers were like this, the staff immediately gave feedback to the editor-in-chief.

"What? You said that academician Qin has contributed to us?" Luo Gang was startled when he heard it.

Although he is the editor-in-chief of "Shuimu Natural Science Journal", his status is completely incomparable with Qin Yuanqing, and even worse than Yan Ning. Just like Yan Ning, the paper will not be submitted to "Shuimu Natural Science Journal", but It is submitted to top international journals such as "Nature", "Science", and "Cell".

Then Luo Gang realized that the opportunity of "Journal of Shuimu Natural Sciences" had come, and Luo Gang ecstatically called the executive deputy editor, deputy editor, and director of the editorial committee.

"Lao Luo, are you right?" Executive deputy editor Zhong Weimin seemed to think he heard it wrong.

"Look, here are the papers. There are nine papers in total, all about myocarditis." Luo Gang said, "But I don't understand this, so I have to find experts to review the papers."

Others saw that the corresponding author of the paper was signed by Qin Yuanqing, six of the nine papers were written by Yan Ning, and three were written by Guo Zhenhua.

"Lao Luo, what else is there to review? Who doesn't know now? Academician Qin's laboratory is the only one in the country, and it is among the best in the world. Can you find a bigger expert to review the manuscript?" Zhong Weimin curled his lips and said: "Still Why not study "Shuimu Mathematics Chronicle" and "Physics and Engineering" and publish papers directly."

Others think so!
Look, everyone was pretty much the same at first, but after only a few years of hard work, "Shuimu Mathematics Chronicle" and "Physics and Engineering" have left them behind and become first-class Chinese and international first-class journals, and must-orders for major universities and related companies around the world Journals, although the two journals still belong to Shuimu Publishing Center, they have their own independent office, and the reviewers they invite are all big names in the industry, and the papers they accept are all from all over the world. It is not easy for first-class scholars.

And the biggest credit for this is Qin Yuanqing, "Shuimu Mathematics Chronicle" and "Physics and Engineering" are completely lying wins.

The emperor takes turns to do it, come to my house next year!
Finally now, it's their turn for "Journal of Shuimu Natural Sciences"!

When they think that "Journal of Shuimu Natural Sciences" will advance by leaps and bounds to become a world-class journal in their hands, then their death is worth it.

Therefore, for the nine papers, "Shuimu Natural Science Journal" directly published a special issue, and published the papers without changing a word.

So, "Shuimu Natural Science Journal" became popular!
In the whole of China, everyone knew that Qin Yuanqing was not doing his job properly. He set up a laboratory and switched to chemistry and physics.

The previous lithium-air battery shocked the whole world and caused a great turmoil in the energy structure. The lithium battery that was originally developed in a hurry was frozen in the cold northwest wind before it reached its peak. The price of oil dropped sharply just as it was about to rise. There was a wave.

So as soon as I heard that the laboratory published nine papers in the "Shuimu Natural Science Journal", these papers immediately exploded.

Even medical research institutions and hospitals immediately ordered "Shuimu Natural Science Journal", so that the original 2 volumes of "Shuimu Natural Science Journal" were ordered in less than a day, "Shuimu Natural Science Journal" The Journal of Science had to be reprinted.

A day later, major medical research institutes, especially those working on myocarditis, conducted experiments based on what was written in the paper.

As a result, the blood of the sick mice was tested, and the proportion, quantity, serum changes and related data of various immune cells were basically consistent with the paper.

About the 'myocarditis specific factor', also found, and the paper is generally the same.

All the researchers who conducted the verification were shocked and heartbroken.It is important to know that the national scientific research grants hundreds of millions to tens of millions of dollars every year, just to understand the pathological mechanism, but so far the research results are still very little.

If there is no accident, such a pathological mechanism project will continue to be studied in the next few years or more than ten years, and a large amount of funds will continue to be invested.

But now, less than a year after the establishment of Qin Yuanqing's laboratory, he has solved the mechanism of viral myocarditis and used it to solve the specific medicine for this pathology.

I don’t know how many researchers, weeping bitterly, they really lived on dogs.

The popularity and influence of the thesis is fermenting, and it is still expanding, from China to the surrounding areas, and then to the entire world.

But before the thesis was published abroad, several major medical giants had approached Qin Yuanqing through various relationships.

"Academician Qin, this is President Zhou of Shanghai Pharmaceuticals (Group) Co., Ltd." Principal Chen introduced a middle-aged man.

Shanghai Pharmaceuticals (Group) Co., Ltd. is a state-owned pharmaceutical industry group with an annual turnover of about 1400 billion yuan and belongs to the top 500 enterprises in China.

Qin Yuanqing frowned slightly. These companies really belonged to dogs. It was less than three days after the paper was published, and they had already found connections.

Then look at other people, including Huaxia Pharmaceutical Corporation, Yangcheng Pharmaceutical Group Co., Ltd., TJ City Pharmaceutical Group Co., Ltd., Harbin Pharmaceutical Group Co., Ltd., etc. It can be said that all ten giants of Huaxia Pharmaceutical have arrived.

The bosses of these pharmaceutical groups all said politely and flatteringly. There was really no way. Qin Yuanqing was different from other researchers. Ten thousand.But Qin Yuanqing was different, Qin Yuanqing himself was a super rich man, and even they felt the pressure due to his terrifying wealth.

The net worth of more than 2000 billion U.S. dollars is higher than the market value of these top ten pharmaceutical companies. What's more, Qin Yuanqing's status is higher than them. He can directly reach Tianting, but they are still It's a grade or two worse.

They didn't have much friendship with Qin Yuanqing, so they paid a lot of favors, and after seven turns and eight turns, they finally got in touch with Principal Chen to get in touch with Qin Yuanqing.

"Bosses came to see me, what's your business?" Qin Yuanqing didn't know them well, so naturally he didn't give them a good look.

Originally, he was going to attend the World Congress of Chinese Mathematicians. This year, the [-]th World Congress of Chinese Mathematicians was held at Shuimu University. About [-] mathematicians from all over the world gathered in Tsinghua University.

Although the conference will officially open tomorrow, some guests, Qin Yuanqing, still need to be received in person. After all, he is now a big banner of Chinese mathematicians, and he also needs to promote exchanges between Chinese mathematicians at home and abroad.

Before that, Qin Yuanqing donated 5000 million to the World Congress of Chinese Mathematicians to encourage the exchange of mathematicians at home and abroad, as well as to train and support the younger generation of mathematicians.

In the end, Principal Chen begged him to come to the principal's office, saying that if he didn't come, he would be shameless.

The bosses of the top ten pharmaceutical companies couldn't help but feel their hearts jump when they heard the words, and their eyelids couldn't help but twitch.

If it were other people, seeing such an attitude, they would have taken action to teach the young people a lesson, but at this time, no one dared to fart.

Sure enough, just as Qin Yuanqing thought, these people came here for the special medicine for myocarditis, and they all wanted to obtain a patent authorization.

Qin Yuanqing sighed inwardly.

To be honest, these domestic pharmaceutical companies are very disappointing. Huaxia's huge pharmaceutical market allows overseas pharmaceutical giants to conquer the city and make a lot of profits every year.

And obviously having a huge market should have a strong bargaining power, just like going to the market to buy a large number of materials, it is much cheaper than individual small purchases, this truth is known even to grandparents.

But every year, the negotiations are defeated, pitifully, and then the giants of overseas pharmaceutical companies are allowed to poke huge profits. The Huaxia pharmaceutical market is like a girl in tulle, allowing the giants of overseas pharmaceutical companies to play however they want.

 Ask for a subscription~~Recently, the subscription has dropped a bit
  
 
(End of this chapter)

Tap the screen to use advanced tools Tip: You can use left and right keyboard keys to browse between chapters.

You'll Also Like